{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:28:21Z","timestamp":1793089701123,"version":"4.5.0"},"reference-count":134,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Primary liver cancer (PLC), which includes hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA), remains a leading cause of cancer-related death worldwide. Chronic liver diseases, such as hepatitis B and C infections and metabolic dysfunction-associated steatotic liver disease (MASLD), are key risk factors for PLC. Metabolic reprogramming, a defining feature of cancer, enables liver cancer cells to adapt to the demands of rapid proliferation and the challenging tumor microenvironment (TME). This manuscript examines the pivotal role of metabolic reprogramming in PLC, with an emphasis on the alterations in glucose, lipid, and amino acid metabolism that drive tumor progression. The Warburg effect, marked by increased glycolysis, facilitates rapid energy production and biosynthesis of cellular components in HCC. Changes in lipid metabolism, including elevated\n                    <jats:italic>de novo<\/jats:italic>\n                    fatty acid synthesis and lipid oxidation, support membrane formation and energy storage essential for cancer cell survival. Amino acid metabolism, particularly glutamine utilization, supplies critical carbon and nitrogen for nucleotide synthesis and maintains redox homeostasis. These metabolic adaptations not only enhance tumor growth and invasion but also reshape the TME, promoting immune escape. Targeting these metabolic pathways presents promising therapeutic opportunities for PLC. This review underscores the interaction between metabolic reprogramming and tumor immunity, suggesting potential metabolic targets for innovative therapeutic strategies. A comprehensive understanding of PLC\u2019s intricate metabolic landscape may lead to more effective treatments and better patient outcomes. Integrating metabolomics, genomics, and proteomics in future research will be vital for identifying precise therapeutic targets and advancing personalized therapies for liver cancer.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2024.1454161","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:11:55Z","timestamp":1731543115000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["The role of metabolic reprogramming in liver cancer and its clinical perspectives"],"prefix":"10.3389","volume":"14","author":[{"given":"Mengxiao","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MinMing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.08.013","article-title":"Mechanisms and implications of metabolic heterogeneity in cancer","volume":"30","author":"Kim","year":"2019","journal-title":"Cell Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Sci (New York N.Y.)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1042\/BST20160094","article-title":"The Warburg effect: 80 years on","volume":"44","author":"Potter","year":"2016","journal-title":"Biochem Soc Trans"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrg1606","article-title":"Mitochondrial DNA mutations in human disease","volume":"6","author":"Taylor","year":"2005","journal-title":"Nat Rev Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012419-032711","article-title":"Mitochondrial dynamics and its involvement in disease","volume":"15","author":"Chan","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02903-0","article-title":"Targeting KRAS in cancer","volume":"30","author":"Singhal","year":"2024","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrm4007","article-title":"p53 in survival, death and metabolic health: a lifeguard with a licence to kill","volume":"16","author":"Kruiswijk","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molmed.2024.03.008","article-title":"Exploiting pancreatic cancer metabolism: challenges and opportunities","volume":"30","author":"De Santis","year":"2024","journal-title":"Trends Mol Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.cell.2021.03.059","article-title":"The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4","volume":"184","author":"Csibi","year":"2021","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10112","article-title":"Crucial role of the pentose phosphate pathway in Malignant tumors","volume":"17","author":"Jin","year":"2019","journal-title":"Oncol Lett"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.81","article-title":"Serine and one-carbon metabolism in cancer","volume":"16","author":"Yang","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.10.005","article-title":"Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment","volume":"43","author":"Apostolova","year":"2022","journal-title":"Trends Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0217-8","article-title":"Metabolic rearrangements in primary liver cancers: cause and consequences","volume":"16","author":"Satriano","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-13-0308","article-title":"Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080596","article-title":"GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis","volume":"174","author":"Amann","year":"2009","journal-title":"Am J Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000093","article-title":"Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma","volume":"33","author":"Paudyal","year":"2008","journal-title":"Int J Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41467-017-02733-4","article-title":"Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin","volume":"9","author":"DeWaal","year":"2018","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3364-3","article-title":"Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma","volume":"60","author":"Guzman","year":"2015","journal-title":"Digestive Dis Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.v234.2","article-title":"Caveolin enhances hepatocellular carcinoma cell metabolism, migration, and invasion in vitro via a hexokinase 2-dependent mechanism","volume":"234","author":"Chai","year":"2019","journal-title":"J Cell Physiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3358","article-title":"Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology","volume":"15","author":"Ji","year":"2023","journal-title":"Sci Trans Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jcmgh.2017.05.004","article-title":"Identification of the consistently altered metabolic targets in human hepatocellular carcinoma","volume":"4","author":"Nwosu","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"24136","DOI":"10.1038\/srep24136","article-title":"The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy","volume":"6","author":"Faloppi","year":"2016","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(15)60353-8","article-title":"Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma","volume":"14","author":"Wang","year":"2015","journal-title":"Hepatobiliary pancreatic Dis international: HBPD Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000005","article-title":"Metabolic reprogramming and its clinical implication for liver cancer","volume":"78","author":"Yang","year":"2023","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","article-title":"Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma","volume":"5","author":"Yang","year":"2023","journal-title":"Nat Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"106270","DOI":"10.1016\/j.phrs.2022.106270","article-title":"Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells","volume":"181","author":"Pan","year":"2022","journal-title":"Pharmacol Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41467-022-28618-9","article-title":"Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmy009","article-title":"Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition","volume":"50","author":"Lu","year":"2018","journal-title":"Acta Biochim Biophys Sin"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-011-9912-1","article-title":"O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcino ma following liver transplantation","volume":"29","author":"Zhu","year":"2012","journal-title":"Med Oncol (Northwood London England)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"43842","DOI":"10.1038\/srep43842","article-title":"High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation","volume":"7","author":"Phoomak","year":"2017","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/HEP.0000000000000553","article-title":"Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma","volume":"79","author":"Li","year":"2024","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S163266","article-title":"Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma","volume":"11","author":"Lin","year":"2018","journal-title":"OncoTargets Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma","volume":"140","author":"Calvisi","year":"2011","journal-title":"Gastroenterology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28415","article-title":"Acetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients","volume":"63","author":"Wang","year":"2016","journal-title":"Hepatology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.696961","article-title":"Targeting fatty acid synthase modulates metabolic pathways and inhibits cholangiocarcinoma cell progression","volume":"12","author":"Tomacha","year":"2021","journal-title":"Front Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2183-2","article-title":"The gluconeogenic enzyme PCK1 phosphorylates INSIG1\/2 for lipogenesis","volume":"580","author":"Xu","year":"2020","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"14689","DOI":"10.1038\/ncomms14689","article-title":"Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival","volume":"8","author":"Nelson","year":"2017","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/cancers10110447","article-title":"Lipid metabolic reprogramming in hepatocellular carcinoma","volume":"10","author":"Nakagawa","year":"2018","journal-title":"Cancers"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31391","article-title":"Lipid remodeling in hepatocyte proliferation and hepatocellular carcinoma","volume":"73","author":"Hall","year":"2021","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1038\/s41467-018-06931-6","article-title":"Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling","volume":"9","author":"Liang","year":"2018","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"100479","DOI":"10.1016\/j.jhepr.2022.100479","article-title":"Lipid alterations in chronic liver disease and liver cancer","volume":"4","author":"Paul","year":"2022","journal-title":"JHEP reports: Innovation Hepatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0987-8","article-title":"Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma","volume":"567","author":"Jiang","year":"2019","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2018.04.038","article-title":"Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts","volume":"429","author":"Yang","year":"2018","journal-title":"Cancer Lett"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1053\/j.gastro.2013.01.054","article-title":"Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes","volume":"144","author":"Budhu","year":"2013","journal-title":"Gastroenterology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"16294","DOI":"10.1038\/srep16294","article-title":"Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma","volume":"5","author":"Murakami","year":"2015","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3892\/ijo.2020.5152","article-title":"Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review)","volume":"58","author":"Fan","year":"2021","journal-title":"Int J Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.026","article-title":"Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis","volume":"72","author":"Ding","year":"2020","journal-title":"J Hepatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cmet.2022.06.010","article-title":"GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment","volume":"34","author":"Missiaen","year":"2022","journal-title":"Cell Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3557","article-title":"Serine, glycine and one-carbon units: cancer metabolism in full circle","volume":"13","author":"Locasale","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","article-title":"One-carbon metabolism in health and disease","volume":"25","author":"Ducker","year":"2017","journal-title":"Cell Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.118","article-title":"One-carbon metabolism in cancer","volume":"116","author":"Newman","year":"2017","journal-title":"Br J Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.393","article-title":"Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells","volume":"4","author":"Tedeschi","year":"2013","journal-title":"Cell Death Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1158\/0008-5472.CAN-21-1020","article-title":"The protein kinase activity of NME7 activates wnt\/\u03b2-catenin signaling to promote one-carbon metabolism in hepatocellular carcinoma","volume":"82","author":"Ren","year":"2022","journal-title":"Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cmet.2022.04.006","article-title":"Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth","volume":"34","author":"Mukha","year":"2022","journal-title":"Cell Metab"},{"key":"B65","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41392-022-01017-8","article-title":"Dietary folate drives methionine metabolism to promote cancer development by stabilizing MAT IIA","volume":"7","author":"Li","year":"2022","journal-title":"Signal transduction targeted Ther"},{"key":"B66","doi-asserted-by":"publisher","first-page":"20210008","DOI":"10.1259\/bjro.20210008","article-title":"Impact of (18)F-FDG-PET\/CT on clinical management in patients with cholangiocellular carcinoma","volume":"3","author":"Kiefer","year":"2021","journal-title":"BJR Open"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026015","article-title":"Prognostic value of metabolic parameters measured by pretreatment dual-time-point 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in patients with intrahepatic or perihilar cholangiocarcinoma: A STROBE study","volume":"100","author":"Hwang","year":"2021","journal-title":"Medicine"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2014.03.008","article-title":"Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma","volume":"45","author":"Kubo","year":"2014","journal-title":"Hum Pathol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10185","article-title":"Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma","volume":"17","author":"Sanmai","year":"2019","journal-title":"Oncol Lett"},{"key":"B70","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41419-018-0494-0","article-title":"PGC1\u03b1 promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effect","volume":"9","author":"Dan","year":"2018","journal-title":"Cell Death Dis"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2019.8.issue-5","article-title":"SIRT3 elicited an anti-Warburg effect through HIF1\u03b1\/PDK1\/PDHA1 to inhibit cholangiocarcinoma tumorigenesis","volume":"8","author":"Xu","year":"2019","journal-title":"Cancer Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.12.031","article-title":"Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma","volume":"74","author":"Raggi","year":"2021","journal-title":"J Hepatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neo.2019.10.004","article-title":"Glutamine deprivation counteracts hypoxia-induced chemoresistance","volume":"22","author":"Wappler","year":"2020","journal-title":"Neoplasia (New York N.Y.)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28508","article-title":"Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans","volume":"63","author":"Li","year":"2016","journal-title":"Hepatology"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32344","article-title":"Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids","volume":"76","author":"Ruiz de Gauna","year":"2022","journal-title":"Hepatology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28496","article-title":"FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling","volume":"63","author":"Guan","year":"2016","journal-title":"Hepatology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40170-021-00266-5","article-title":"Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma","volume":"9","author":"Padthaisong","year":"2021","journal-title":"Cancer Metab"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1022","article-title":"IFN\u03b1 Potentiates anti-PD-1 efficacy by remodeling glucose metabolism in the hepatocellular carcinoma microenvironment","volume":"12","author":"Hu","year":"2022","journal-title":"Cancer Discovery"},{"key":"B79","doi-asserted-by":"publisher","first-page":"111122","DOI":"10.1016\/j.celrep.2022.111122","article-title":"Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells","volume":"40","author":"Gu","year":"2022","journal-title":"Cell Rep"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade5111","article-title":"Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development","volume":"9","author":"Cheu","year":"2023","journal-title":"Sci Adv"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.10.021","article-title":"Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma","volume":"74","author":"Wang","year":"2021","journal-title":"J Hepatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v14.i6.1124","article-title":"Glutamine deprivation impairs function of infiltrating CD8(+) T cells in hepatocellular carcinoma by inducing mitochondrial damage and apoptosis","volume":"14","author":"Wang","year":"2022","journal-title":"World J gastrointestinal Oncol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.3390\/cells11233924","article-title":"Unbalanced glutamine partitioning between CD8T cells and cancer cells accompanied by immune cell dysfunction in hepatocellular carcinoma","volume":"11","author":"Chen","year":"2022","journal-title":"Cells"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer","volume":"20","author":"Leone","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3A0318-108R","article-title":"Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis","volume":"105","author":"Handa","year":"2019","journal-title":"J leukocyte Biol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12967-021-03034-7","article-title":"Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages","volume":"19","author":"Sun","year":"2021","journal-title":"J Trans Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.5847","article-title":"A single-center experience of sorafenib monotherapy in patients with advanced intrahepatic cholangiocarcinoma","volume":"13","author":"Pan","year":"2017","journal-title":"Oncol Lett"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30656","article-title":"Causes of hOCT1-dependent cholangiocarcinoma resistance to sorafenib and sensitization by tumor-selective gene therapy","volume":"70","author":"Lozano","year":"2019","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.018","article-title":"The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study","volume":"71","author":"Allen","year":"2019","journal-title":"J Hepatol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.09.012","article-title":"Association between non-alcoholic fatty liver disease and cancer incidence rate","author":"Kim","year":"2017","journal-title":"J Hepatol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.01.010","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma","volume":"65","author":"Zoller","year":"2016","journal-title":"Metabolism: Clin Exp"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0787","article-title":"Body mass index, waist circumference, diabetes, and risk of liver cancer for U.S. Adults","volume":"76","author":"Campbell","year":"2016","journal-title":".Cancer Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000388","article-title":"Obesity is independently associated with increased risk of hepatocellular cancer-related mortality: A systematic review and meta-analysis","volume":"41","author":"Gupta","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1910_18","article-title":"Subcutaneous adipose tissue & visceral adipose tissue","volume":"149","author":"Mittal","year":"2019","journal-title":"Indian J Med Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.09.020","article-title":"Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver","volume":"71","author":"Marchesini","year":"2019","journal-title":"J Hepatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mad.2016.07.001","article-title":"Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis","volume":"157","author":"Bozaykut","year":"2016","journal-title":"Mech Ageing Dev"},{"key":"B97","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1755-1536-1-5","article-title":"Redox mechanisms in hepatic chronic wound healing and fibrogenesis","volume":"1","author":"Novo","year":"2008","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B98","doi-asserted-by":"publisher","first-page":"8543763","DOI":"10.1155\/2018\/8543763","article-title":"Molecular pathogenesis of nonalcoholic steatohepatitis- (NASH-) related hepatocellular carcinoma","volume":"2018","author":"Kutlu","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.792667","article-title":"The role of notch signaling pathway in non-alcoholic fatty liver disease","volume":"8","author":"Xu","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B100","doi-asserted-by":"publisher","first-page":"19377","DOI":"10.1038\/srep19377","article-title":"Notch1 deficiency decreases hepatic lipid accumulation by induction of fatty acid oxidation","volume":"6","author":"Song","year":"2016","journal-title":"Sci Rep"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.7150\/jca.26847","article-title":"The carcinogenic role of the notch signaling pathway in the development of hepatocellular carcinoma","volume":"10","author":"Huang","year":"2019","journal-title":"J Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.09.032","article-title":"Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features","volume":"74","author":"Zhu","year":"2021","journal-title":"J Hepatol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/oby.22873","article-title":"Hepatocyte notch signaling deregulation related to lipid metabolism in women with obesity and nonalcoholic fatty liver","volume":"28","author":"Auguet","year":"2020","journal-title":"Obes (Silver Spring Md.)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"101143","DOI":"10.1016\/j.molmet.2020.101143","article-title":"Metabolic drivers of non-alcoholic fatty liver disease","volume":"50","author":"Bence","year":"2021","journal-title":"Mol Metab"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093256","article-title":"AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma","volume":"9","author":"Cheng","year":"2014","journal-title":"PloS One"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1038\/s41598-019-39556-w","article-title":"Metformin and glucose starvation decrease the migratory ability of hepatocellular carcinoma cells: targeting AMPK activation to control migration","volume":"9","author":"Ferretti","year":"2019","journal-title":"Sci Rep"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i45.9933","article-title":"Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects","volume":"22","author":"Shang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.v6i15","article-title":"By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice","volume":"6","author":"Dai","year":"2015","journal-title":"Oncotarget"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.5510","article-title":"2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells","volume":"13","author":"Tomizawa","year":"2017","journal-title":"Oncol Lett"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2009.07.007","article-title":"A small molecule that blocks fat synthesis by inhibiting the activation of SREBP","volume":"16","author":"Kamisuki","year":"2009","journal-title":"Chem Biol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-017-0027-2","article-title":"An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer","volume":"50","author":"Chen","year":"2018","journal-title":"Nat Genet"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1021\/jm200304y","article-title":"Synthesis and evaluation of diarylthiazole derivatives that inhibit activation of sterol regulatory element-binding proteins","volume":"54","author":"Kamisuki","year":"2011","journal-title":"J medicinal Chem"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32359","article-title":"Therapeutic efficacy of FASN inhibition in preclinical models of HCC","volume":"76","author":"Wang","year":"2022","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2363","article-title":"A phase I study of ABC294640, a first-in-class sphingosine kinase-2 inhibitor, in patients with advanced solid tumors","volume":"23","author":"Britten","year":"2017","journal-title":"Clin Cancer research: an Off J Am Assoc Cancer Res"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.425","article-title":"Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts","volume":"111","author":"Chiu","year":"2014","journal-title":"Br J Cancer"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.56749","article-title":"A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer","volume":"9","author":"Jin","year":"2020","journal-title":"eLife"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202000549","article-title":"Tumor-targeted inhibition of monocarboxylate transporter 1 improves T-cell immunotherapy of solid tumors","volume":"10","author":"Huang","year":"2021","journal-title":"Advanced healthcare materials"},{"key":"B118","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13046-019-1189-9","article-title":"Effects of short-term fasting on cancer treatment","volume":"38","author":"de Groot","year":"2019","journal-title":"J Exp Clin Cancer research: CR"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/tcm.10005","article-title":"Effects of fasting and intermittent fasting on rat hepatocarcinogenesis induced by diethylnitrosamine","volume":"22","author":"Rocha","year":"2002","journal-title":"Teratogenesis carcinogenesis mutagenesis"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/18.1.159","article-title":"The effect of two periods of short-term fasting during the promotion stage of hepatocarcinogenesis in rats: the role of apoptosis and cell proliferation","volume":"18","author":"Hikita","year":"1997","journal-title":"Carcinogenesis"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/20.10.1979","article-title":"Effect of fasting\/refeeding on the incidence of chemically induced hepatocellular carcinoma in the rat","volume":"20","author":"Tomasi","year":"1999","journal-title":"Carcinogenesis"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-018-0014-x","article-title":"Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism","volume":"40","author":"Liu","year":"2019","journal-title":"Acta pharmacologica Sin"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-0758","article-title":"Aspirin in hepatocellular carcinoma","volume":"81","author":"Ricciotti","year":"2021","journal-title":"Cancer Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2015.02.003","article-title":"mTOR inhibitor therapy: Does it prevent HCC recurrence after liver transplantation","volume":"29","author":"Duvoux","year":"2015","journal-title":"Transplant Rev (Orlando Fla.)"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-015-0221-y","article-title":"A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors","volume":"33","author":"Chu","year":"2015","journal-title":"Investigational New Drugs"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2263","article-title":"A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer","volume":"29","author":"Halford","year":"2023","journal-title":"Clin Cancer research: an Off J Am Assoc Cancer Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-018-3619-3","article-title":"A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors","volume":"82","author":"Sehdev","year":"2018","journal-title":"Cancer chemotherapy Pharmacol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014961","article-title":"Study protocol of a phase IB\/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours","volume":"7","author":"Molenaar","year":"2017","journal-title":"BMJ Open"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.3836","article-title":"Final overall survival efficacy results of ivosidenib for patients with advanced cholangiocarcinoma with IDH1 mutation: the phase 3 randomized clinical clarIDHy trial","volume":"7","author":"Zhu","year":"2021","journal-title":"JAMA Oncol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30189-X","article-title":"Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study","volume":"4","author":"Lowery","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02492","article-title":"Phase I study of the mutant IDH1 inhibitor ivosidenib: safety and clinical activity in patients with advanced chondrosarcoma","volume":"38","author":"Tap","year":"2020","journal-title":"J Clin oncology: Off J Am Soc Clin Oncol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0382-T","article-title":"An essential requirement for the SCAP\/SREBP signaling axis to protect cancer cells from lipotoxicity","volume":"73","author":"Williams","year":"2013","journal-title":"Cancer Res"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.04.021","article-title":"Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma","volume":"71","author":"Jouve","year":"2019","journal-title":"J Hepatol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12072-020-10120-3","article-title":"Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child-Pugh B cirrhosis","volume":"15","author":"Blanc","year":"2021","journal-title":"Hepatol Int"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1454161\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:12:02Z","timestamp":1731543122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1454161\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":134,"alternative-id":["10.3389\/fonc.2024.1454161"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1454161","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"article-number":"1454161"}}